Skip to main content
SpringerLink
Log in

Review of osteoporotic fracture research in Endocrinology and Metabolism Research Institute; where we started and where to go

Journal of Diabetes & Metabolic Disorders (2021)Cite this article

Abstract

Purpose

Osteoporotic fractures impose a vast burden on the health system, especially in countries with an old population or an ageing trend such as Iran. This study reviews the articles published by the Endocrinology and Metabolism Research Institute (EMRI) to map and summarize the evidence, identify key themes and highlight research gaps to plan future research.

Method

We searched for studies affiliated with EMRI on osteoporotic fracture. Scopus, PubMed, Google Scholar, Scientific Information Database (SID) and Persian databases were used, without restricting time and language. All papers published up to December 2019 were retrieved and merged using Endnote software. Two independent researchers reviewed documents, and non-related papers were removed from the collection. The reference lists of the relevant articles were reviewed to avoid missing any publication. All papers addressing any aspects of fragility fractures were included. Meeting abstracts and letters to the editor were excluded. The visualization of the co-authorship network was illustrated with VOSveiwer program software.

Results

The total number of 20 papers, published between 2004 and 2019 were included in our study. “Larijani, B” with 12, “Keshtkar, A”, “Abolhassani, F”, and “Soltani, A” with five papers were the most prolific authors. Six out of 20 (30 %) of the papers were published in the last three years. Among different perspectives of osteoporotic fractures, addressed by EMRI, four main categories of articles were defined including incidence (n = 7), related factors (n = 9), fracture risk assessment (n = 2), and the burden of osteoporotic fractures in Iran (n = 4). There was no updated information about the incidence of osteoporotic fracture and its burden in recent years.

Conclusions

Considering the importance of osteoporotic fractures in Iran with an ageing trend, Osteoporosis Research Centers can play an essential role in providing evidence for policymakers. Worldwide, there is a large care gap to assess bone health and start treatments after fragility fractures. Accordingly, following international recommendations, practical interventions are required to fill this gap. EMRI began developing the “Registry of osteoporosis” and also pilot the “Fracture Liaison Services”, as an operative model to address the existing care gap and implement applied research in this science area.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1

Data svailability

Not applicable.

References

  1. Johnell O, Kanis J. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006;17(12):1726–33.

    Article  CAS  Google Scholar 

  2. Baddoura R, Hoteit M, Fuleihan GE-H. Osteoporotic fractures, DXA, and fracture risk assessment: meeting future challenges in the eastern Mediterranean region. J Clin Densitom. 2011;14(4):384–94.

    Article  CAS  Google Scholar 

  3. Manoochehry S, Rasouli HR. Iranian population policy and aging: new health concerns. Int J Travel Med Glob Health. 2017;5(2):70–1.

    Article  Google Scholar 

  4. EMRI Strategic Plan: Endocrinology and Metabolism Research Institute. 2019. Available from: http://emri.tums.ac.ir/EN/Item/12889, 25/April/2020.

  5. Abolhassani F, Mohammadi M, Soltani A. Burden of osteoporosis in Iran. Iran J Public Health. 2004;33(Supple 1):18–28.

    Google Scholar 

  6. Moayyeri A, Soltani A, Abolhassani F. Incidence of hip fractures among Iranian elderly population. Iran J Public Health. 2004;33:29–33.

    Google Scholar 

  7. Zolfaghari M, Keshtkar AA., Maghbouli J, Kazemnejad A, Ardeshir Larijani MB*. The incidence of osteoporotic hip fracture in 3 years fallow up of Iranian Multicenters Osteoporosis Study (IMOS). J Reprod Infertil Winter 2005;6(1(21)Osteoporosis special issue):37–42.

  8. Abolhassani F, et al. Incidence and characteristics of falls leading to hip fracture in Iranian population. Bone. 2006;39(2):408–13.

    Article  Google Scholar 

  9. Moayyeri A, et al. Epidemiology of hip fracture in Iran: results from the Iranian Multicenter Study on Accidental Injuries. Osteoporos Int. 2006;17(8):1252–7.

    Article  CAS  Google Scholar 

  10. Ahmadi-Abhari S, Moayyeri A, Abolhassani F. Burden of hip fracture in Iran. Calcif Tissue Int. 2007;80(3):147–53.

    Article  CAS  Google Scholar 

  11. Saghafi H, et al. Osteoimmunological insight in to vertebral fractures in osteoporosis. Iran J Public Health. 2008:7–15.

  12. Aliasgarzadeh A, et al. Incidence of osteoporotic hip fracture in above 50 year old peoples of Tabriz in years 2004–2006. Iran J Endocrinol Metab. 2009;10(6):563–656.

    Google Scholar 

  13. Rahnavard Z, et al. The incidence of osteoporotic Hip fracture: Iranian Multicenter osteoporosis study (IMOS). Res J Biol Sci. 2009;4(2):171–3.

    Google Scholar 

  14. Hossein-Nezhad A, et al. Variation in the COX-2 gene may modify the effect of alendronate on vertebral fracture prevention. Eur J Inf Syst. 2010;8(3):143–9.

    CAS  Google Scholar 

  15. Salari P, Abdollahi M. Long term bisphosphonate use in osteoporotic patients; a step forward, two steps back. J Pharm Pharm Sci. 2012;15(2):305–17.

    Article  CAS  Google Scholar 

  16. Shahnazari B, et al. Estimating the avoidable burden of certain modifiable risk factors in osteoporotic hip fracture using Generalized Impact Fraction (GIF) model in Iran. J Diabetes Metab Disord. 2013;12(1):10.

    Article  Google Scholar 

  17. Ghafoori S, et al. The risk of osteoporotic fractures and its associating risk factors according to the FRAX model in the Iranian patients: a follow-up cohort. J Diabetes Metab Disord. 2014;13(1):93.

    Article  Google Scholar 

  18. Amininezhad F, et al. Evaluation of the validity of the FRAX® algorithm for predicting risk of osteoporotic fracture in Iran. Osteologie. 2015;24(03):183–6.

    Article  Google Scholar 

  19. Maghbooli Z, et al. Direct costs of osteoporosis-related hip fractures: protocol for a cross-sectional analysis of a national database. BMJ Open. 2017;7(4):e014898.

    Article  Google Scholar 

  20. Sadeghi O, et al. Abdominal obesity and risk of hip fracture: a systematic review and meta-analysis of prospective studies. Adv Nutr. 2017;8(5):728–38.

    Article  Google Scholar 

  21. Malmir H, et al. Adherence to Mediterranean diet in relation to bone mineral density and risk of fracture: A systematic review and meta-analysis of observational studies. Eur J Nutr. 2018;57(6):2147–60.

    Article  Google Scholar 

  22. Malmir H, Larijani B, Esmaillzadeh A. Consumption of milk and dairy products and risk of osteoporosis and hip fracture: a systematic review and Meta-analysis. Crit Rev Food Sci Nutr. 2019;60(10):1722–37.

    Article  Google Scholar 

  23. Salari-Moghaddam A, et al. Metformin use and risk of fracture: a systematic review and meta-analysis of observational studies. Osteoporos Int. 2019;30(6):1167–73.

    Article  CAS  Google Scholar 

  24. Khashayar P, et al. FRAX-based intervention and assessment thresholds for osteoporosis in Iran. Osteoporos Int. 2019;30(11):2225–30.

    Article  CAS  Google Scholar 

  25. Sharif PS, Abdollahi M. A systematic review on the relationship between β-blockers and bone health. Int J Pharmacol. 2010;6:577–83.

    Article  CAS  Google Scholar 

  26. Keshtkar A, et al. The incidence of osteoporotic hip fracture in Iran, a review. Osteoporos Int. 2010;21:S707–S707.

    Google Scholar 

  27. Kung AW, Huang Q. Genetic and environmental determinants of osteoporosis. J Musculoskelet Neuronal Interact. 2007;7(1):26.

    CAS  PubMed  Google Scholar 

  28. Kanis JA, et al. FRAX® and its applications to clinical practice. Bone. 2009;44(5):734–43.

    Article  Google Scholar 

  29. Bliuc D, et al. Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res. 2015;30(4):637–46.

    Article  Google Scholar 

  30. Center JR, et al. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353(9156):878–82.

    Article  CAS  Google Scholar 

  31. Bliuc D, et al. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301(5):513–21.

    Article  CAS  Google Scholar 

  32. Walters S, et al. Fracture liaison services: improving outcomes for patients with osteoporosis. Clin Interv Aging. 2017;12:117.

    Article  Google Scholar 

  33. Marsh D, et al. Coordinator-based systems for secondary prevention in fragility fracture patients. Osteoporos Int. 2011;22(7):2051–65.

    Article  CAS  Google Scholar 

  34. Nakayama A, et al. Evidence of effectiveness of a fracture liaison service to reduce the re-fracture rate. Osteoporos Int. 2016;27(3):873–9.

    Article  CAS  Google Scholar 

  35. Wu C-H, et al. Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: A systematic literature review and meta-analysis. Bone. 2018;111:92–100.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Noushin Fahimfar, Mahnaz Sanjari, Kazem Khalagi & Afshin Ostovar

  2. Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran

    Safoora Gharibzadeh

  3. School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran

    Mohammad Javad Mansourzadeh

  4. Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Neda Mehrdad

  5. Evidence Based Practice Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Rasha Atlasi

  6. Department of Medical Library and Information Science, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran

    Rasha Atlasi

  7. Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Hossein Adibi

  8. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Bagher Larijani

Authors
  1. Noushin Fahimfar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Safoora Gharibzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mahnaz Sanjari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mohammad Javad Mansourzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kazem Khalagi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Neda Mehrdad
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rasha Atlasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Hossein Adibi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bagher Larijani
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Afshin Ostovar
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Afshin Ostovar.

Ethics declarations

Conflicts of interest/Competing interests

The authors declare that they have no conflict of interest.

Ethics approval

Not applicable.

Consent for publication

Not applicable. 

Code availability

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

ESM 1

(DOCX 15 kb)

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fahimfar, N., Gharibzadeh, S., Sanjari, M. et al. Review of osteoporotic fracture research in Endocrinology and Metabolism Research Institute; where we started and where to go. J Diabetes Metab Disord (2021). https://doi.org/10.1007/s40200-021-00733-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40200-021-00733-2

Keywords

search

Navigation